| 1AZV | A:; B: | FAMILIAL ALS MUTANT G37R CUZNSOD (HUMAN) |
| 1BA9 | A: | THE SOLUTION STRUCTURE OF REDUCED MONOMERIC SUPEROXIDE DISMUTASE, NMR, 36 STRUCTURES |
| 1DSW | A: | THE SOLUTION STRUCTURE OF A MONOMERIC, REDUCED FORM OF HUMAN COPPER, ZINC SUPEROXIDE DISMUTASE BEARING THE SAME CHARGE AS THE NATIVE PROTEIN |
| 1FUN | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | SUPEROXIDE DISMUTASE MUTANT WITH LYS 136 REPLACED BY GLU, CYS 6 REPLACED BY ALA AND CYS 111 REPLACED BY SER (K136E, C6A, C111S) |
| 1HL4 | A:; B:; C:; D: | THE STRUCTURE OF APO TYPE HUMAN CU, ZN SUPEROXIDE DISMUTASE |
| 1HL5 | A:; K:; L:; M:; N:; O:; P:; Q:; S:; B:; C:; D:; E:; F:; G:; H:; I:; J: | THE STRUCTURE OF HOLO TYPE HUMAN CU, ZN SUPEROXIDE DISMUTASE |
| 1KMG | A: | THE SOLUTION STRUCTURE OF MONOMERIC COPPER-FREE SUPEROXIDE DISMUTASE |
| 1L3N | A:; B: | THE SOLUTION STRUCTURE OF REDUCED DIMERIC COPPER ZINC SOD: THE STRUCTURAL EFFECTS OF DIMERIZATION |
| 1MFM | A: | MONOMERIC HUMAN SOD MUTANT F50E/G51E/E133Q AT ATOMIC RESOLUTION |
| 1N18 | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | THERMOSTABLE MUTANT OF HUMAN SUPEROXIDE DISMUTASE, C6A, C111S |
| 1N19 | A:; B: | STRUCTURE OF THE HSOD A4V MUTANT |
| 1OEZ | W:; X:; Y:; Z: | ZN HIS46ARG MUTANT OF HUMAN CU, ZN SUPEROXIDE DISMUTASE |
| 1OZT | G:; H:; I:; J:; K:; L:; M:; N: | CRYSTAL STRUCTURE OF APO-H46R FAMILIAL ALS MUTANT HUMAN CU, ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 2.5A RESOLUTION |
| 1OZU | A:; B: | CRYSTAL STRUCTURE OF FAMILIAL ALS MUTANT S134N OF HUMAN CU, ZN SUPEROXIDE DISMUTASE (CUZNSOD) TO 1.3A RESOLUTION |
| 1P1V | A:; B:; C: | CRYSTAL STRUCTURE OF FALS-ASSOCIATED HUMAN COPPER-ZINC SUPEROXIDE DISMUTASE (CUZNSOD) MUTANT D125H TO 1.4A |
| 1PTZ | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN CU, ZN SUPEROXIDE DISMUTASE, FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS (FALS) MUTANT H43R |
| 1PU0 | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | STRUCTURE OF HUMAN CU,ZN SUPEROXIDE DISMUTASE |
| 1RK7 | A: | SOLUTION STRUCTURE OF APO CU,ZN SUPEROXIDE DISMUTASE: ROLE OF METAL IONS IN PROTEIN FOLDING |
| 1SOS | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | ATOMIC STRUCTURES OF WILD-TYPE AND THERMOSTABLE MUTANT RECOMBINANT HUMAN CU, ZN SUPEROXIDE DISMUTASE |
| 1SPD | A:; B: | AMYOTROPHIC LATERAL SCLEROSIS AND STRUCTURAL DEFECTS IN CU,ZN SUPEROXIDE DISMUTASE |
| 1UXL | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | I113T MUTANT OF HUMAN SOD1 |
| 1UXM | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L: | A4V MUTANT OF HUMAN SOD1 |
| 2AF2 | A:; B: | SOLUTION STRUCTURE OF DISULFIDE REDUCED AND COPPER DEPLETED HUMAN SUPEROXIDE DISMUTASE |
| 2C9S | A:; F: | 1.24 ANGSTROMS RESOLUTION STRUCTURE OF ZN-ZN HUMAN SUPEROXIDE DISMUTASE |
| 2C9U | A:; F: | 1.24 ANGSTROMS RESOLUTION STRUCTURE OF AS-ISOLATED CU-ZN HUMAN SUPEROXIDE DISMUTASE |
| 2C9V | A:; F: | ATOMIC RESOLUTION STRUCTURE OF CU-ZN HUMAN SUPEROXIDE DISMUTASE |
| 2GBT | A:; B:; C:; D: | C6A/C111A CUZN SUPEROXIDE DISMUTASE |
| 2GBU | A:; B:; C:; D: | C6A/C111A/C57A/C146A APO CUZN SUPEROXIDE DISMUTASE |
| 2GBV | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | C6A/C111A/C57A/C146A HOLO CUZN SUPEROXIDE DISMUTASE |
| 2NNX | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE H46R, H48Q DOUBLE MUTANT OF HUMAN [CU-ZN] SUPEROXIDE DISMUTASE |
| 2R27 | A:; B: | CONSTITUTIVELY ZINC-DEFICIENT MUTANT OF HUMAN SUPEROXIDE DISMUTASE (SOD), C6A, H80S, H83S, C111S |
| 2V0A | A:; F: | ATOMIC RESOLUTION CRYSTAL STRUCTURE OF HUMAN SUPEROXIDE DISMUTASE |
| 2VR6 | A:; F: | CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.3 A RESOLUTION |
| 2VR7 | A:; F: | CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.58 A RESOLUTION |
| 2VR8 | A:; F: | CRYSTAL STRUCTURE OF G85R ALS MUTANT OF HUMAN CU,ZN SUPEROXIDE DISMUTASE (CUZNSOD) AT 1.36 A RESOLUTION |
| 2WKO | A:; F: | STRUCTURE OF METAL LOADED PATHOGENIC SOD1 MUTANT G93A. |
| 2WYT | A:; F: | 1.0 A RESOLUTION STRUCTURE OF L38V SOD1 MUTANT |
| 2WYZ | A:; F: | L38V SOD1 MUTANT COMPLEXED WITH UMP |
| 2WZ0 | A:; F: | L38V SOD1 MUTANT COMPLEXED WITH ANILINE. |
| 2WZ5 | A:; F: | L38V SOD1 MUTANT COMPLEXED WITH L-METHIONINE. |
| 2WZ6 | A:; F: | G93A SOD1 MUTANT COMPLEXED WITH QUINAZOLINE. |
| 2ZKW | A:; B: | CRYSTAL STRUCTURE OF HUMAN CU-ZN SUPEROXIDE DISMUTASE MUTANT G85R IN SPACE GROUP P21 |
| 2ZKX | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN CU-ZN SUPEROXIDE DISMUTASE MUTANT G85R IN SPACE GROUP I212121 |
| 2ZKY | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | CRYSTAL STRUCTURE OF HUMAN CU-ZN SUPEROXIDE DISMUTASE MUTANT G93A |
| 3CQP | A:; B:; C:; D: | HUMAN SOD1 G85R VARIANT, STRUCTURE I |
| 3CQQ | A:; B: | HUMAN SOD1 G85R VARIANT, STRUCTURE II |
| 3ECU | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN APO CU,ZN SUPEROXIDE DISMUTASE (SOD1) |
| 3ECV | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE ALS-RELATED PATHOLOGICAL MUTANT I113T OF HUMAN APO CU,ZN SUPEROXIDE DISMUTASE (SOD1) |
| 3ECW | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE ALS-RELATED PATHOLOGICAL MUTANT T54R OF HUMAN APO CU,ZN SUPEROXIDE DISMUTASE (SOD1) |
| 3GQF | A:; B:; C:; D:; E:; F: | STRUCTURAL AND BIOPHYSICAL PROPERTIES OF THE PATHOGENIC SOD1 VARIANT H46R/H48Q |
| 3GTV | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L: | HUMAN-MOUSE SOD1 CHIMERA |
| 3GZO | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | HUMAN SOD1 G93A VARIANT |
| 3GZP | A:; B:; C:; D: | HUMAN SOD1 G93A METAL-FREE VARIANT |
| 3GZQ | A:; B: | HUMAN SOD1 A4V METAL-FREE VARIANT |
| 3H2P | A:; B: | HUMAN SOD1 D124V VARIANT |
| 3H2Q | A:; B:; C:; D: | HUMAN SOD1 H80R VARIANT, P21 CRYSTAL FORM |
| 3HFF | A: | MONOMERIC HUMAN CU,ZN SUPEROXIDE DISMUTASE WITHOUT ZN LIGANDS |
| 3K91 | A:; B: | POLYSULFANE BRIDGE IN CU-ZN SUPEROXIDE DISMUTASE |
| 3QQD | A:; B: | HUMAN SOD1 H80R VARIANT, P212121 CRYSTAL FORM |
| 3RE0 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN APO CU,ZN SUPEROXIDE DISMUTASE (SOD1) COMPLEXED WITH CISPLATIN |
| 3T5W | A:; B:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M: | 2ME MODIFIED HUMAN SOD1 |
| 4A7G | F: | STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 4-METHYLPIPERAZIN-1-YL)QUINAZOLINE IN THE P21 SPACE GROUP. |
| 4A7Q | A:; F: | STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 4-(4-METHYL-1,4-DIAZEPAN-1-YL)QUINAZOLINE IN THE P21 SPACE GROUP. |
| 4A7S | A:; F: | STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH 5-FLUOROURIDINE IN THE P21 SPACE GROUP |
| 4A7T | A:; F: | STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH ISOPROTERANOL IN THE P21 SPACE GROUP |
| 4A7U | A:; F: | STRUCTURE OF HUMAN I113T SOD1 COMPLEXED WITH ADRENALINE IN THE P21 SPACE GROUP. |
| 4A7V | A:; F: | STRUCTURE OF HUMAN I113T SOD1 MUTANT COMPLEXED WITH DOPAMINE IN THE P21 SPACE GROUP |
| 4B3E | A:; B:; C:; D:; E:; F:; G:; H:; I:; J: | STRUCTURE OF COPPER-ZINC SUPEROXIDE DISMUTASE COMPLEXED WITH BICARBONATE. |
| 4FF9 | A:; B: | CRYSTAL STRUCTURE OF CYSTEINYLATED WT SOD1. |
)
)